Effect of MRA on Cardiovascular Disease in Patients With Hypertension and Hyperaldosteronemia

NCT05688579 · clinicaltrials.gov ↗

PHASE4

Phase

ENROLLING_BY_INVITATION

Status

8000

Enrollment

OTHER

Sponsor class

Conditions

Hypertension
Hyperaldosteronaemia

Interventions

DRUG: Mineralocorticoid Receptor Antagonists(MRAs)
OTHER: Blank control

Sponsor

Nanfang Li